Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 14351 - 14375 of 14879 in total
BMS-564929 is an investigational therapeutic agent built to be a selective androgen receptor modulator (SARM). So far, it has been developed by Bristol-Myers Squibb for the symptomatic treatment of andropause.
Experimental
Experimental
Experimental
Investigational
MK-4965 is an HIV-1 reverse transcriptase inhibitor.
Experimental
Evatanepag has been used in trials studying the treatment of Tibial Fractures.
Investigational
Iguratimod is under investigation in Rheumatoid Arthritis.
Investigational
NLX-P101, gene therapy is developed by Neurologix to treat Parkinson’s disease. The gene is glutamic acid decarboxylase (GAD), whose product synthesizes the major inhibitory neurotransmitter in the brain, (gamma)-aminobutyric acid (GABA), and targets the subthalamic nucleus (STN), which is overactive in patients with Parkinson’s disease. NLX-P101 is being evaluated as...
Investigational
Matched Description: … product synthesizes the major inhibitory neurotransmitter in the brain, (gamma)-aminobutyric acid (GABA), and
BMS-903452 has been used in trials studying the treatment of Diabetes.
Investigational
Imiglitazar has been used in trials studying the treatment of Diabetes Mellitus.
Investigational
E6005 has been used in trials studying the treatment of Atopic Dermatitis.
Investigational
MRX-I has been used in trials studying the treatment of Bacterial Infections.
Investigational
Displaying drugs 14351 - 14375 of 14879 in total